Peptides Weight LossMetabolic
5-Amino-1MQ
5-amino-1MQ · 1MQ · 5-Amino-1-methylquinolinium
Small-molecule NNMT inhibitor investigated for fat loss and metabolic research; limited human data.
🚧 Expanded guide coming soon. This compound has PK data and a source — a full overview, mechanism, and dosing guide is pending editorial review.
Pharmacokinetic summary
- Model tier
- Simple (t½ + F, Tmax estimated)
- Half-life
- 0.5 days
- Bioavailability
- 50%
- Typical dose
- 25–100 mg
Related compounds
AICAR
AMPK-activating nucleotide studied as an exercise mimetic for endurance and metabolic research.
SLU-PP-332
Estrogen-related receptor agonism ("exercise mimetic") researched for metabolic and endurance effects.
Semaglutide Injection (Ozempic/Wegovy)
Long-acting GLP-1 receptor agonist for type 2 diabetes and weight loss; weekly injection.
Comments
Loading comments…